Author(s): Kong L, Cooperwood JS, Oh CH, Chu CK, Boudinot FD
3'-Azido-2',3'-dideoxyuridine (AZDU) is a nucleoside analog structurally similar to zidovudine (AZT) with proven activity against human immunodeficiency virus (HIV). The purpose of this study was to develop and validate a high-performance liquid chromatographic (HPLC) method to quantitatively determine AZDU and its novel prodrugs in rat plasma simultaneously. A reversed-phase gradient elution HPLC method was developed to quantitate AZDU and its prodrugs, N3-pivaloyloxymethyl-3'-azido-2',3'-dideoxyuridine (I), 5'-pivaloyloxymethyl-3'-azido-2',3'-dideoxyuridine (II), 5'-O-valinyl-3'-azido-2',3'-dideoxyuridine hydrochloride (III) and 5'-O-phenylalanyl-3'-azido-2',3'-dideoxyuridine hydrochloride (IV), in rat plasma. AZDU and its prodrugs were analyzed using an octadecyl silane column with a mobile phase consisting of 0.04 microM sodium acetate buffer, pH 5.0, and acetonitrile, running in a segmented gradient manner at a flow rate of 2 ml/min. Acetonitrile was increased from 10 to 50% during the first 8 min by 5% per min, followed by 10% per min until it reached 90% acetonitrile. 3'-Azido-2',3'-dideoxy-5-ethyluridine (CS-85) was used as an internal standard (25 microg/ml). Compounds were detected by UV absorption at 261 nm. Extraction recoveries for all compounds were greater than 80%. Retention times of AZDU, CS-85, prodrugs I, II, III and IV were 3.3, 5.2, 9.1, 8.8, 6.3 and 7.3 min, respectively. Calibration plots were linear over the range of 0.25-100 microg/ml for AZDU and prodrugs II, III, and IV and 0.5-100 microg/ml for prodrug I. The limit of quantitation was 0.25 microg/ml for prodrugs II, III and IV and 0.5 microg/ml for prodrug I. The intra- and inter-day variations were less than 10% and accuracies were greater than 90%. This method is rapid, sensitive and reproducible for the determination of AZDU and prodrugs in rat plasma.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/14522042
Author(s): McLeod AD, Fedorak RN, Friend DR, Tozer TN, Cui N
Author(s): McLeod AD, Friend DR, Tozer TN
Author(s): Fedorak RN, Haeberlin B, Empey LR, Cui N, Nolen H 3rd, et al.
Author(s): Fedorak RN, Cui N, Friend DR, Madsen KL, Empey LR
Author(s): Hirabayashi H, Takahashi T, Fujisaki J, Masunaga T, Sato S, et al.
Author(s): Chourasia MK, Jain SK
Author(s): Teng XW, Wang SW, Davies NM
Author(s): Zhao X, Chen D, Li K, Wang D
Author(s): Duan Y, Yu J, Liu S, Ji M
Author(s): Cassano R, Trombino S, Cilea A, Ferrarelli T, Muzzalupo R, et al.
Author(s): Tanaka S, Matsui H, Kasai M, Kunishiro K, Kakeya N, et al.
Author(s): Reiner A
Author(s): Friedrich RB, Ravanello A, Cichota LC, Rolim CMB, Beck RCR